Figure 1. Early FCH-PET/CT complete response on abiraterone treatment.
Baseline FCH-PET/CT shows a single left iliac nodal lesion, 5 week FCH-PET/CT resolution correlated with PSA decline and then with undetectable PSA levels (PSA < 0.03 ng/mL) after 6 months of abiraterone therapy.